Kotyark Industries has received a significant order worth Rs 173.45 crore from Indian Oil Corporation (IOCL), Bharat Petroleum Corporation Limited (BPCL), and Hindustan Petroleum Corporation Limited (HPCL). The order is for biodiesel allocation for supplies in Gujarat during June–August 2026, pursuant to an OMC tender. The scheduled supply period is 92 days from the date of award of the contract. The company's market capitalisation currently stands at Rs 475 crores.

Prior to this large order, Kotyark Industries had also received Letters of Intent (LOIs) worth Rs 15.41 crore from BPCL and HPCL for biodiesel supply. That award represents a pre-contract stage, with revenue recognition commencing only after formal work order issuance. Together, these disclosures reflect a meaningful build-up in the company's order pipeline from public sector oil marketing companies (OMCs).

Order in Financial Context

The Rs 173.45 crore order value represents approximately 267.50% of the company's average quarterly revenue of Rs 64.83 crore. The total visible order book, including the Rs 15.41 crore LOI, stands at Rs 188.86 crore. The trailing twelve-month revenue stands at Rs 259.30 crore. The order book coverage is approximately 2.68 quarters of average quarterly revenue based on the primary order alone. As this is a confirmed order linked to an OMC tender, it represents a tangible step towards revenue recognition upon execution of the supply schedule.

The following table summarises the recent order disclosures:

Company Order Track Record

The company has disclosed two notable orders in the recent period. The order history table below summarises the inflows:

These disclosures make the current biodiesel supply agreements the primary drivers of the visible order book in the recent past, with no other order disclosures found in Q4FY26, Q3FY26, or Q4FY25.

Execution and Revenue Quality

Kotyark Industries has demonstrated improving profitability metrics in recent quarters. In Q4FY26, the company reported revenue of Rs 63.70 crore and net profit of Rs 9.40 crore, with an operating profit margin (OPM) of 30.07%. This marks an improvement from Q3FY26, where revenue was Rs 103.90 crore but OPM compressed to 9.52% due to lower operating profit of Rs 9.90 crore. In Q4FY25, revenue was Rs 20.20 crore with an OPM of 28.20%.

The high OPM in Q4FY26 suggests improved execution efficiency or a favorable product mix, although the absolute revenue run-rate remains volatile quarter-on-quarter.

Revenue Growth

Kotyark Industries' annual revenue has grown from Rs 288.80 crore in FY25 to Rs 314.90 crore in FY26, representing a year-on-year (YoY) growth of +9.00%. This growth trajectory followed a substantial jump of +107.60% in FY24, indicating periods of rapid expansion interspersed with more moderate growth phases.

Working Capital and Execution Capacity

The company's balance sheet appears robust for executing new contracts. The current ratio stands at 3.22x, indicating ample liquidity to manage working capital requirements for the upcoming biodiesel supply. Total Liabilities/Equity is low at 0.43x, suggesting minimal financial leverage. However, operating cashflow was negative at -Rs 3.90 crore in FY26, compared to positive Rs 30.90 crore in FY25. This negative cash conversion warrants monitoring to ensure that receivables from clients like IOCL, BPCL, and HPCL do not stretch the working capital cycle as volumes increase.

What to Watch

• Supply Execution: Monitor the commencement of biodiesel supplies scheduled within 92 days of award and the subsequent revenue recognition.
• LOI Conversion: Track whether the Rs 15.41 crore LOI from BPCL and HPCL converts into formal work orders and eventual revenue.
• Execution Rate: Monitor whether the Q4FY26 revenue momentum of Rs 63.70 crore can be sustained, given the volatility seen in Q3FY26 and Q4FY25.
• Cash Conversion: With negative operating cashflow in FY26, watch for improvements in days sales outstanding (DSO) as the company scales up biodiesel supplies.
• Client Concentration: IOCL, BPCL, and HPCL are major public sector undertakings; securing their business reduces customer acquisition risk but may introduce payment cycle delays typical of large PSUs.

Key Observations

• Contract progression: The filing confirms a large order value of Rs 173.45 crore from IOCL, BPCL, and HPCL for biodiesel supplies in Gujarat. Revenue recognition will depend on the actual supply volumes delivered within the 92-day window scheduled for June–August 2026.
• Pre-contract pipeline: The Rs 15.41 crore LOI from BPCL and HPCL adds to the near-term order pipeline, pending formal work order issuance.
• Valuation check (as of 12 Aug 2026): P/E of 24.80x against ROCE of 17.25%. Valuation appears to be pricing in execution improvement not yet fully visible in return ratios, though the gap is moderate. MCap stands at Rs 475 crores.
• Promoter holding: Moved from 63.84% in Q4FY26 to 57.34% in Q1FY27, a 6.50 pp reduction. This selling activity by promoters should be monitored for further dilution or strategic shifts.
• Cash conversion: Operating cashflow of -Rs 3.90 crore in FY26; backlog is not converting to cash efficiently, and receivables or working capital cycle may be stretched despite strong profitability on paper.

Kotyark Industries has proposed a final dividend of ₹5 per equity share for the financial year ended March 31, 2026, signaling confidence in its cash generation capabilities. The payout, amounting to an aggregate of ₹5,13,95,580, is contingent upon approval by shareholders at the company’s 10th Annual General Meeting scheduled for August 22, 2026. Notably, this dividend figure remains fixed despite a previously approved 10:1 bonus share issue; if the bonus shares are allotted before the dividend payment, the per-share payout will be proportionately adjusted to maintain the total aggregate payout unchanged.

The AGM will be conducted via Video Conference or Other Audio Visual Means (OAVM), with remote e-voting facilitated by National Securities Depository Limited (NSDL). Voting opens on August 19, 2026, and closes on August 21, 2026. Shareholders holding securities as of the record date, August 14, 2026, are eligible to receive the dividend, which will be paid within 30 days of the meeting’s conclusion.

Beyond the dividend, the Board of Directors has placed several strategic resolutions before shareholders to enhance financial flexibility. These include seeking approval under Section 180(1)(c) of the Companies Act, 2013, to borrow monies up to an aggregate outstanding limit of ₹750 crore. This authorization allows the company to raise funds from banks, financial institutions, or through instruments like debentures and commercial papers, exceeding the aggregate of its paid-up capital and free reserves if necessary.

Additionally, shareholders are asked to approve limits for loans, guarantees, and investments under Section 186 of the Companies Act, 2013, up to ₹500 crore. The company also seeks ratification for creating charges, mortgages, or hypothecation on its movable and immovable properties under Section 180(1)(a), secured against borrowings up to the approved ₹750 crore limit.

Key Resolutions and Financial Disclosures

The AGM agenda includes critical governance and operational approvals, detailed below:

Related Party Transactions and Governance

A significant portion of the special business involves approving material related-party transactions (RPTs) with subsidiary Kotyark Bio Specialities Limited (KBSL). The Board seeks an omnibus approval for transactions up to ₹250 crore for FY27, covering sale/purchase of goods, loans, and services. This limit represents 79.40% of the company’s annual consolidated turnover of ₹314.87 crore in FY26. KBSL, in which Kotyark Industries holds an 81.63% stake, reported a turnover of ₹51.63 crore and a profit after tax of ₹3.24 crore in FY26.

Governance changes include the re-appointment of Mrs. Dhruti Mihir Shah as Whole-Time Director, who retires by rotation. She is eligible and offers herself for re-appointment. The company also seeks to appoint M/s. Talati & Talati LLP as its new Statutory Auditors, replacing M/s. Manubhai & Shah LLP, whose tenure expires. Furthermore, the appointment of M/s. Mittal V. Kothari & Associates as Secretarial Auditor for five years (FY26–FY30) requires ratification following the company’s migration to the Main Board.

The Board also recommends revising the remuneration of Mr. Brijkumar Gaurang Shah, Chief Production Executive and a related party, to not exceed ₹42,00,000 per annum, effective from the conclusion of the AGM.